Dual-Modality Optical/PET Imaging of PARP1 in Glioblastoma

被引：60
|
作者：
Carlucci, Giuseppe [1 ]
Carney, Brandon [1 ,2 ,3 ]
Brand, Christian [1 ]
Kossatz, Susanne [1 ]
Irwin, Christopher P. [1 ]
Carlin, Sean D. [1 ]
Keliher, Edmund J. [4 ]
Weber, Wolfgang [1 ,5 ]
Reiner, Thomas [1 ,5 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10065 USA
[2] CUNY Hunter Coll, Dept Chem & Biochem, New York, NY 10065 USA
[3] CUNY, Grad Ctr, PhD Program Chem, New York, NY 10018 USA
[4] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA
[5] Weill Cornell Med Coll, New York, NY 10065 USA
来源：
MOLECULAR IMAGING AND BIOLOGY | 2015年 / 17卷 / 06期
基金：
美国国家科学基金会;
关键词：
PARP1; Glioblastoma; PET; Fluorescence; Multimodality; Imaging; U87; MG; IN-VIVO PET; OVARIAN-CANCER; SINGLE-CELL; ACID; INHIBITOR; RESECTION; OLAPARIB; DEFLUORINATION; EXCHANGE; THERAPY;
D O I：
10.1007/s11307-015-0858-0
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
The current study presents [F-18]PARPi-FL as a bimodal fluorescent/positron emission tomography (PET) agent for PARP1 imaging. [F-18]PARPi-FL was obtained by F-19/F-18 isotopic exchange and PET experiments, biodistribution studies, surface fluorescence imaging, and autoradiography carried out in a U87 MG glioblastoma mouse model. [F-18]PARPi-FL showed high tumor uptake in vivo and ex vivo in small xenografts (< 2 mm) with both PET and optical imaging technologies. Uptake of [F-18]PARPi-FL in blocked U87 MG tumors was reduced by 84 % (0.12 +/- 0.02 %injected dose/gram (%ID/g)), showing high specificity of the binding. PET imaging showed accumulation in the tumor (1 h p.i.), which was confirmed by ex vivo phosphor autoradiography. The fluorescent component of [F-18]PARPi-FL enables cellular resolution optical imaging, while the radiolabeled component of [F-18]PARPi-FL allows whole-body deep-tissue imaging of malignant growth.
引用
收藏
页码：848 / 855
页数：8
相关论文
共 50 条
  • [41] Miniature all-optical probe for photoacoustic and ultrasound dual-modality imaging
    Li, Guangyao
    Guo, Zhendong
    Chen, Sung-Liang
    PHOTONS PLUS ULTRASOUND: IMAGING AND SENSING 2018, 2018, 10494
  • [42] Photoactivatable Fluorescent Tags for Dual-Modality Positron Emission Tomography Optical Imaging
    Guillou, Amaury
    Nisli, Eda
    Klingler, Simon
    Linden, Anthony
    Holland, Jason P.
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (01) : 811 - 823
  • [43] Dual-Modality Endoscopic Probe for Optical Coherence Tomography Imaging and pH Sensing
    Wang Jianping
    Chen Minghui
    Tan Weijie
    Feng Yuanyuan
    Zheng Gang
    CHINESE JOURNAL OF LASERS-ZHONGGUO JIGUANG, 2020, 47 (09):
  • [44] Tumor Targeting Chitosan Nanoparticles for Dual-Modality Optical/MR Cancer Imaging
    Nam, Taehwan
    Park, Sangjin
    Lee, Seung-Young
    Park, Kyeongsoon
    Choi, Kuiwon
    Song, In Chan
    Han, Moon Hee
    Leary, James J.
    Yuk, Simseok Andrew
    Kwon, Ick Chan
    Kim, Kwangmeyung
    Jeong, Seo Young
    BIOCONJUGATE CHEMISTRY, 2010, 21 (04) : 578 - 582
  • [45] In Vivo Tumor-Targeted Dual-Modality PET/Optical Imaging with a Yolk/Shell-Structured Silica Nanosystem
    Shi, Sixiang
    Chen, Feng
    Goel, Shreya
    Graves, Stephen A.
    Luo, Haiming
    Theuer, Charles P.
    Engle, Jonathan W.
    Cai, Weibo
    NANO-MICRO LETTERS, 2018, 10 (04)
  • [46] In Vivo Tumor-Targeted Dual-Modality PET/Optical Imaging with a Yolk/Shell-Structured Silica Nanosystem
    Sixiang Shi
    Feng Chen
    Shreya Goel
    Stephen A.Graves
    Haiming Luo
    Charles P.Theuer
    Jonathan W.Engle
    Weibo Cai
    Nano-Micro Letters, 2018, (04) : 111 - 121
  • [47] In Vivo Tumor-Targeted Dual-Modality PET/Optical Imaging with a Yolk/Shell-Structured Silica Nanosystem
    Sixiang Shi
    Feng Chen
    Shreya Goel
    Stephen A. Graves
    Haiming Luo
    Charles P. Theuer
    Jonathan W. Engle
    Weibo Cai
    Nano-Micro Letters, 2018, 10
  • [48] In Vivo Tumor-Targeted Dual-Modality PET/Optical Imaging with a Yolk/Shell-Structured Silica Nanosystem
    Sixiang Shi
    Feng Chen
    Shreya Goel
    Stephen AGraves
    Haiming Luo
    Charles PTheuer
    Jonathan WEngle
    Weibo Cai
    Nano-Micro Letters, 2018, 10 (04) : 111 - 121
  • [49] Selective PARP1 inhibitors, PARP1-based dual-target inhibitors, PROTAC PARP1 degraders, and prodrugs of PARP1 inhibitors for cancer therapy
    Peng, Xiaopeng
    Pan, Wanyi
    Jiang, Feng
    Chen, Weiming
    Qi, Zetao
    Peng, Weijie
    Chen, Jianjun
    PHARMACOLOGICAL RESEARCH, 2022, 186
  • [50] Optimization of ODAP-Urea-based dual-modality PSMA targeting probes for sequential PET-CT and optical imaging
    Li, Yuan
    Duan, Xiaojiang
    Xu, Hongchuang
    Zhang, Jingming
    Zhou, Haoxi
    Zhang, Xiaojun
    Zhang, Jinming
    Yang, Zhi
    Hu, Zhenhua
    Zhang, Ning
    Tian, Jie
    Yang, Xing
    BIOORGANIC & MEDICINAL CHEMISTRY, 2022, 66
12345